KRYS
Price
$162.00
Change
-$2.97 (-1.80%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
4.77B
47 days until earnings call
MIST
Price
$1.93
Change
-$0.00 (-0.00%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
164.04M
49 days until earnings call
Interact to see
Advertisement

KRYS vs MIST

Header iconKRYS vs MIST Comparison
Open Charts KRYS vs MISTBanner chart's image
Krystal Biotech
Price$162.00
Change-$2.97 (-1.80%)
Volume$7.03K
Capitalization4.77B
Milestone Pharmaceuticals
Price$1.93
Change-$0.00 (-0.00%)
Volume$1.51K
Capitalization164.04M
KRYS vs MIST Comparison Chart in %
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. MIST commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Buy and MIST is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (KRYS: $164.97 vs. MIST: $1.93)
Brand notoriety: KRYS and MIST are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 67% vs. MIST: 77%
Market capitalization -- KRYS: $4.77B vs. MIST: $164.04M
KRYS [@Biotechnology] is valued at $4.77B. MIST’s [@Biotechnology] market capitalization is $164.04M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileMIST’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • MIST’s FA Score: 0 green, 5 red.
According to our system of comparison, MIST is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 7 TA indicator(s) are bullish while MIST’s TA Score has 5 bullish TA indicator(s).

  • KRYS’s TA Score: 7 bullish, 3 bearish.
  • MIST’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, KRYS is a better buy in the short-term than MIST.

Price Growth

KRYS (@Biotechnology) experienced а +6.86% price change this week, while MIST (@Biotechnology) price change was -1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

KRYS is expected to report earnings on Nov 10, 2025.

MIST is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.78B) has a higher market cap than MIST($164M). KRYS YTD gains are higher at: 5.304 vs. MIST (-18.220). KRYS has higher annual earnings (EBITDA): 158M vs. MIST (-51.72M). KRYS has more cash in the bank: 682M vs. MIST (43.4M). KRYS has less debt than MIST: KRYS (9.68M) vs MIST (56.4M). KRYS has higher revenues than MIST: KRYS (359M) vs MIST (0).
KRYSMISTKRYS / MIST
Capitalization4.78B164M2,912%
EBITDA158M-51.72M-306%
Gain YTD5.304-18.220-29%
P/E Ratio33.53N/A-
Revenue359M0-
Total Cash682M43.4M1,571%
Total Debt9.68M56.4M17%
FUNDAMENTALS RATINGS
KRYS vs MIST: Fundamental Ratings
KRYS
MIST
OUTLOOK RATING
1..100
7879
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
50
Fair valued
PROFIT vs RISK RATING
1..100
36100
SMR RATING
1..100
53100
PRICE GROWTH RATING
1..100
5245
P/E GROWTH RATING
1..100
81100
SEASONALITY SCORE
1..100
3085

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MIST's Valuation (50) in the Pharmaceuticals Major industry is in the same range as KRYS (66). This means that MIST’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for MIST (100). This means that KRYS’s stock grew somewhat faster than MIST’s over the last 12 months.

KRYS's SMR Rating (53) in the Pharmaceuticals Major industry is somewhat better than the same rating for MIST (100). This means that KRYS’s stock grew somewhat faster than MIST’s over the last 12 months.

MIST's Price Growth Rating (45) in the Pharmaceuticals Major industry is in the same range as KRYS (52). This means that MIST’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's P/E Growth Rating (81) in the Pharmaceuticals Major industry is in the same range as MIST (100). This means that KRYS’s stock grew similarly to MIST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSMIST
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
75%
Bearish Trend 8 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MIST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLEAX13.940.18
+1.31%
GS Energy Infrastructure Fd A Shares
FGREX9.260.04
+0.43%
Invesco Global Real Estate R6
RERAX60.050.02
+0.03%
American Funds EUPAC R1
NINAX23.51-0.16
-0.68%
Neuberger Berman Intrinsic Value A
APHYX25.95-0.43
-1.63%
Artisan Developing World Institutional

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-0.27%
XNCR - KRYS
51%
Loosely correlated
-0.67%
NUVL - KRYS
50%
Loosely correlated
+2.76%
VRDN - KRYS
49%
Loosely correlated
+0.05%
CGON - KRYS
49%
Loosely correlated
-0.92%
CRNX - KRYS
48%
Loosely correlated
+6.35%
More

MIST and

Correlation & Price change

A.I.dvisor indicates that over the last year, MIST has been loosely correlated with PCVX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MIST jumps, then PCVX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MIST
1D Price
Change %
MIST100%
-3.98%
PCVX - MIST
52%
Loosely correlated
-0.96%
EQ - MIST
41%
Loosely correlated
-2.76%
KRYS - MIST
36%
Loosely correlated
-0.27%
TSHA - MIST
32%
Poorly correlated
+1.74%
JBPHF - MIST
31%
Poorly correlated
N/A
More